Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation

Compounds of formula R1-A-NH-CH(R2)-CO-R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone density, or to inhibit osteoclast differentiation and stimulation, bone resorption and/or loosening of a prosthetic device. The compounds can be a...

Full description

Saved in:
Bibliographic Details
Main Authors KASPRZYKOWSKI FRANCISZEK, ZOLNOWSKA BEATA, GRUBB ANDERS, LERNER ULF, KASPRZYKOWSKA REGINA
Format Patent
LanguageEnglish
Published 27.10.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Compounds of formula R1-A-NH-CH(R2)-CO-R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone density, or to inhibit osteoclast differentiation and stimulation, bone resorption and/or loosening of a prosthetic device. The compounds can be administered as a pharmaceutical composition or in a prosthetic device.
AbstractList Compounds of formula R1-A-NH-CH(R2)-CO-R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone density, or to inhibit osteoclast differentiation and stimulation, bone resorption and/or loosening of a prosthetic device. The compounds can be administered as a pharmaceutical composition or in a prosthetic device.
Author LERNER ULF
KASPRZYKOWSKA REGINA
ZOLNOWSKA BEATA
GRUBB ANDERS
KASPRZYKOWSKI FRANCISZEK
Author_xml – fullname: KASPRZYKOWSKI FRANCISZEK
– fullname: ZOLNOWSKA BEATA
– fullname: GRUBB ANDERS
– fullname: LERNER ULF
– fullname: KASPRZYKOWSKA REGINA
BookMark eNqNjU1Ow0AMhbOARfm5gw8AC4qEyLZVEctKwLpyM29US1M7GptUvRYnJGk4ACv7e8_Wd9NcqSkWzc8WfUgCJVQZOGSAU7ZKUcFxhMYD9RXDuIgpjQWXgkF4xkxMnWmSC7K7dWOFRCeJA-1HBRVzn_6KneYgQV3iPGVhJHqQvQSZB6wr7EFJckadjLOFNZGHHL_Lhe-a68zFcf83bxt623yu3x_R2w7ecwdF7L4-2qeXdvnarpbP_zj5BfwqXuQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US9169289B2
GroupedDBID EVB
ID FETCH-epo_espacenet_US9169289B23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:21:16 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US9169289B23
Notes Application Number: US201414257255
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151027&DB=EPODOC&CC=US&NR=9169289B2
ParticipantIDs epo_espacenet_US9169289B2
PublicationCentury 2000
PublicationDate 20151027
PublicationDateYYYYMMDD 2015-10-27
PublicationDate_xml – month: 10
  year: 2015
  text: 20151027
  day: 27
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies STRONGBONE AB
RelatedCompanies_xml – name: STRONGBONE AB
Score 3.0028565
Snippet Compounds of formula R1-A-NH-CH(R2)-CO-R3 are presented. The compounds can be used to treat or alleviate conditions associated with bone loss or low bone...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151027&DB=EPODOC&locale=&CC=US&NR=9169289B2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEG8IGvVNUSN-5R7MnlwUGNt4WEzYIMSEjwgY3ki3dmEJdkQqxH_Lv9BrKeiLvi3XrM3udh-_9npHyB2t0XparSS27yepjZro2xQxmO16DlewOXmkCih2e25n7DxP6pMCybZ3YXSd0LUujogalaC-S22vFz-bWJHOrVw-xBmS8qf2KIgsg47RfSHMsqJm0Br0o35ohWEwHlq9lwCjoAZiiyZa6z2Moj2lDK3XprqUsvjtUdrHZH-Akwl5QgpclMhhuG28ViIHXXPejY9G9Zan5Gug8k8YB4b_zEqX614CRpywSxW_h4Wpx5QLwAHVJWW14TzkKVBA6Mt0hhZQIxTOQG3EQpwLDnP0l-q9eb7eEJhKbpefiiZzyMQsizMJ6lZInmDQLWHbXUWaVahggCbjzbQEOyPQbo3Cjo0fP90xejoe7thUOydFgUtdEPArqevxtJFgKOgwTim6fL_iIMlFcMWqZVL-c5rLf8auyJGSmHIEVe-aFOX7B79BDy_jWy2bb4j5sUs
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8JAEJ4QNOpNUSM-52B6slGgtOXQmNBCUHlFwHAj2-42NsGWyArxb_kLnS0FveitmU1305nO49udnQG4ZhVWDculQLftINRJE22dEQbTTcsQCjYHd0wBxU7XbI2Mx3F1nINofRcmrRO6TIsjkkYFpO8ytdezn00sL82tnN_6EZGS--bQ8bQMHZP7IpileXWn0e95PVdzXWc00LrPDkVBNcIWdbLWWxRhW0oZGi91dSll9tujNPdhu0-TxfIAciIuwK67brxWgJ1Odt5Nj5nqzQ_hq6_yT7hATv_MIi3XPUeKOHGTKn6Ds6weUxIjDaguKYsV5zEJkSFBX55maCHLhCI4qo1Y9JNY4JT8pXpvmixXBK6S2-WnoskEo_g18iOJ6lZIElDQLXHdXUVmq7CYI5mMt6wl2BFgszF0Wzp9_GTD6MlosGFT5RjyMS11AmiXQtMSYS2gUNDggjFy-XbJIJJJ4IqXi1D8c5rTf8auYLc17LQn7Yfu0xnsKekpp1C2ziEv3z_EBXl76V-mcvoGCPa0Pg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Peptide+derivatives+for+treatment%2C+prevention+or+alleviation+of+a+condition+associated+with+bone+loss+or+low+bone+density+or+to+inhibit+osteoclast+differentiation+and+stimulation&rft.inventor=KASPRZYKOWSKI+FRANCISZEK&rft.inventor=ZOLNOWSKA+BEATA&rft.inventor=GRUBB+ANDERS&rft.inventor=LERNER+ULF&rft.inventor=KASPRZYKOWSKA+REGINA&rft.date=2015-10-27&rft.externalDBID=B2&rft.externalDocID=US9169289B2